227 related articles for article (PubMed ID: 38580886)
1. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
[TBL] [Abstract][Full Text] [Related]
2. Identification of Prognostic Related Genes of Tumor Microenvironment Derived From Esophageal Cancer Patients.
Yuan W; Yan J; Liu H; Li L; Wu B; Guo C; Zhang M
Pathol Oncol Res; 2021; 27():589662. PubMed ID: 34257539
[No Abstract] [Full Text] [Related]
3. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
[TBL] [Abstract][Full Text] [Related]
4. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
[TBL] [Abstract][Full Text] [Related]
6. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment.
Bikfalvi A; Billottet C
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C542-C554. PubMed ID: 31913695
[TBL] [Abstract][Full Text] [Related]
7. Role of chemokines in hepatocellular carcinoma (Review).
Xue D; Zheng Y; Wen J; Han J; Tuo H; Liu Y; Peng Y
Oncol Rep; 2021 Mar; 45(3):809-823. PubMed ID: 33650640
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures.
Zhang Y; Zhu M; Mo J; Xian L
Aging (Albany NY); 2021 Dec; 13(24):26118-26136. PubMed ID: 34954689
[TBL] [Abstract][Full Text] [Related]
10. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
[TBL] [Abstract][Full Text] [Related]
11. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
Yin Z; Ma T; Chen S; Yu M
Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
[TBL] [Abstract][Full Text] [Related]
12. The significance of chemokines in diffuse large B-cell lymphoma: a systematic review and future insights.
Huang Q; Liu F; Shen J
Future Oncol; 2019 Apr; 15(12):1385-1395. PubMed ID: 30880459
[TBL] [Abstract][Full Text] [Related]
13. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
14. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
16. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis.
Li J; Zeng Z; Jiang X; Zhang N; Gao Y; Luo Y; Sun W; Li S; Ren J; Gong Y; Xie C
Sci Rep; 2020 Oct; 10(1):18589. PubMed ID: 33122682
[TBL] [Abstract][Full Text] [Related]
17. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
18. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
19.
Zhang R; Wang H; Xiao J; Lu J; Li M; Zhou Y; Sun H; Liu L; Huang T; Zhao Q
DNA Cell Biol; 2023 Jan; 42(1):27-42. PubMed ID: 36638349
[TBL] [Abstract][Full Text] [Related]
20. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
